The Clorox Company demonstrates a robust commitment to dividends, supported by a long history of consistency. The company's dividend yield of 3.45% and 44 years of uninterrupted payments make it attractive to income-focused investors. However, its payout ratio of over 100% relative to both EPS and free cash flow suggests some sustainability concerns. Let's delve further into the specifics of Clorox's dividend profile to understand its overall appeal.
Clorox operates within the consumer goods sector, known for generating stable cash flows. The company's current dividend yield stands at 3.45%, with a dividend of $4.79 per share. Despite recent pressures, Clorox has maintained dividends for 44 years without any cuts or suspensions.
Detail | Value |
---|---|
Sector | Consumer Goods |
Dividend yield | 3.45% |
Current dividend per share | $4.79 |
Dividend history | 44 years |
Last cut or suspension | None |
Clorox's dividend history is a testament to its resilience, maintaining and increasing dividends over 44 years. This consistency is crucial for long-term investors seeking reliability in returns.
Year | Dividend per Share (USD) |
---|---|
2025 | $2.44 |
2024 | $4.86 |
2023 | $4.76 |
2022 | $4.68 |
2021 | $4.54 |
Understanding dividend growth rates is essential to project future income potential. Clorox's growth indicators suggest a modest, yet stable increase over time.
Time | Growth |
---|---|
3 years | 2.30% |
5 years | 3.77% |
The average dividend growth is 3.77% over 5 years. This shows moderate but steady dividend growth.
Payout ratios provide insight into the sustainability of a company’s dividends. Clorox's payout ratios are high, suggesting aggressive distribution relative to its earnings and cash flow.
Key Figure | Ratio |
---|---|
EPS-based | 129.77% |
Free cash flow-based | 84.93% |
The high EPS payout ratio of 129.77% indicates the dividend payments exceed earnings, which could pose a risk if not supported by strong cash flow management.
Evaluation of cash flow metrics and capital efficiency helps understand Clorox’s financial robustness and capacity to maintain dividends.
2024 | 2023 | 2022 | |
---|---|---|---|
Free Cash Flow Yield | 2.90% | 4.73% | 3.08% |
Earnings Yield | 1.68% | 0.76% | 2.66% |
CAPEX to Operating Cash Flow | 30.50% | 19.69% | 31.93% |
Stock-based Compensation to Revenue | 1.18% | 0.99% | 0.73% |
Free Cash Flow / Operating Cash Flow Ratio | 69.50% | 80.31% | 68.07% |
The metrics indicate stable cash flows, though the increase in CAPEX to cash flow ratios calls for strategic capital allocation reviews.
Analyzing leverage ratios reveals Clorox's financial stability and debt management capability.
2024 | 2023 | 2022 | |
---|---|---|---|
Debt-to-Equity | 8.85 | 13.29 | 5.58 |
Debt-to-Assets | 50.48% | 49.18% | 50.39% |
Debt-to-Capital | 89.85% | 93.00% | 84.80% |
Net Debt to EBITDA | 3.67 | 4.43 | 3.15 |
Current Ratio | 1.03 | 0.95 | 0.97 |
Quick Ratio | 0.63 | 0.59 | 0.54 |
Financial Leverage | 17.53 | 27.02 | 11.08 |
Clorox's high leverage, notably a debt-equity ratio over 8, suggests potential risk, managed by steady operations and cash flows.
Assessing key profitability ratios provides insight into operational efficiency and margin strength.
2024 | 2023 | 2022 | |
---|---|---|---|
Return on Equity | 85.37% | 67.73% | 83.09% |
Return on Assets | 4.87% | 2.51% | 7.50% |
Net Margin | 3.95% | 2.02% | 6.50% |
EBIT Margin | 6.88% | 4.44% | 10.03% |
EBITDA Margin | 10.38% | 7.81% | 13.06% |
Gross Margin | 42.97% | 39.36% | 35.81% |
Research & Development to Revenue | 1.78% | 1.87% | 1.86% |
Clorox's high return on equity highlights superior profit generation, though volatility in net margins suggests cost management challenges.
Analyzing Clorox across multiple dividend-related criteria offers a holistic view of its investment appeal.
Category | Score | |
---|---|---|
Dividend Yield | 3 | |
Dividend Stability | 5 | |
Dividend Growth | 3 | |
Payout Ratio | 2 | |
Financial Stability | 2 | |
Dividend Continuity | 5 | |
Cashflow Coverage | 4 | |
Balance Sheet Quality | 3 |
The Clorox Company's dividend strategy is well-suited for income investors focused on long-term reliability, despite concerns of high payout ratios and leverage. Continued monitoring of cash flows and profitability will be essential for maintaining dividend health.